Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:19:15 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Q:SBFM - SUNSHINE BIOPHARMA INC - http://www.sunshinebiopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SBFM - Q0.10.8613·0.88390.50.8602-0.0148-1.72,399.71,7256,0580.875  0.9337  0.85140.00  0.7519:59:07Apr 1915 min RT 2¢

Recent Trades - Last 10 of 6058
Time ETExPriceChangeVolume
19:59:07Q0.87-0.0053
19:55:32Q0.87-0.005100
19:54:25Q0.8698-0.00524
19:53:28Q0.8699-0.00515
19:49:33Q0.8612-0.013845
19:49:14Q0.87-0.00525
19:45:39Q0.8699-0.005125
19:45:13Q0.8602-0.014811
19:42:49Q0.87-0.00550
19:37:54Q0.8569-0.01811

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-19 08:02U:SBFMNews ReleaseSunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
2024-04-12 09:02U:SBFMNews ReleaseSunshine Biopharma Announces Reverse Stock Split
2024-04-02 13:56U:SBFMSEDAR Audited Annual Financial StatementsSEDAR MD & A
2024-04-02 13:44U:SBFMSEDAR Annual ReportSEDAR Annual Report
2024-04-01 08:03U:SBFMNews ReleaseSunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
2024-02-15 09:16U:SBFMNews ReleaseSunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
2024-02-13 09:04U:SBFMNews ReleaseSunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
2023-12-04 08:30U:SBFMNews ReleaseSunshine Biopharma Moves Principal Office to New York City
2023-11-13 09:44U:SBFMSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-13 09:40U:SBFMSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-13 08:32U:SBFMNews ReleaseSunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition
2023-08-14 14:30U:SBFMSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-11 08:30U:SBFMNews ReleaseSunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
2023-05-16 14:16U:SBFMNews ReleaseAegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)
2023-05-16 09:59U:SBFMNews ReleaseSunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market
2023-05-12 08:00U:SBFMNews ReleaseSunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
2023-05-11 09:00U:SBFMNews ReleaseSunshine Biopharma Reports 2023 First Quarter Results: ‚  Revenues Up 2,100%
2023-05-10 18:38U:SBFMSEDAR MD & ASEDAR MD & A
2023-05-10 18:32U:SBFMSEDAR Interim Financial StatementsSEDAR Interim Financial Statements